Ph2 stud of TORL-1-23 in women with epithelial and fallopian tube cancers (CLDN6)
Phase II Clinical Trial
A Phase 2 Study Evaluating The Efficacy And Safety Of TORL-1-23 In Women With Advanced Platinum Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal And Fallopian Tube Cancers) Expressing Claudin 6 (TORL123-002)